Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1448

1.

Editorial: Lexical Tone Perception in Infants and Young Children: Empirical Studies and Theoretical Perspectives.

Singh L, Burnham D, Hay J, Liu L, Mattock K.

Front Psychol. 2019 May 22;10:1195. doi: 10.3389/fpsyg.2019.01195. eCollection 2019. No abstract available.

2.

Live cell imaging of signaling and metabolic activities.

Depaoli MR, Bischof H, Eroglu E, Burgstaller S, Ramadani-Muja J, Rauter T, Schinagl M, Waldeck-Weiermair M, Hay JC, Graier WF, Malli R.

Pharmacol Ther. 2019 Jun 6. pii: S0163-7258(19)30110-X. doi: 10.1016/j.pharmthera.2019.06.003. [Epub ahead of print] Review.

3.

Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling.

Hay JW.

Value Health. 2019 May;22(5):564-569. doi: 10.1016/j.jval.2019.01.009.

PMID:
31104735
4.

Lay beliefs about risk: relation to risk behaviors and to probabilistic risk perceptions.

Riley KE, Hay JL, Waters EA, Biddle C, Schofield E, Li Y, Orom H, Kiviniemi MT.

J Behav Med. 2019 May 15. doi: 10.1007/s10865-019-00036-1. [Epub ahead of print]

PMID:
31093806
5.

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans.

van Amerongen G, Siebenga PS, Gurrell R, Dua P, Whitlock M, Gorman D, Okkerse P, Hay JL, Butt RP, Groeneveld GJ.

Br J Anaesth. 2019 Jan 31. pii: S0007-0912(18)31374-6. doi: 10.1016/j.bja.2018.12.006. [Epub ahead of print]

PMID:
30915991
6.

The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia.

Ali S, Dunmore HM, Karres D, Hay JL, Salmonsson T, Gisselbrecht C, Sarac SB, Bjerrum OW, Hovgaard D, Barbachano Y, Nagercoil N, Pignatti F.

Oncologist. 2019 May;24(5):e171-e179. doi: 10.1634/theoncologist.2019-0025. Epub 2019 Mar 21.

PMID:
30898889
7.

Parent and child perspectives on perceived barriers to child sun protection and their association with sun protection strategies among children of melanoma survivors.

Wu YP, Parsons BG, Aspinwall LG, Hay JL, Boucher KM, Caputo H, Mooney R, Grossman D, Leachman SA.

Pediatr Dermatol. 2019 May;36(3):317-323. doi: 10.1111/pde.13796. Epub 2019 Mar 20.

PMID:
30895676
8.

pH-Lemon, a Fluorescent Protein-Based pH Reporter for Acidic Compartments.

Burgstaller S, Bischof H, Gensch T, Stryeck S, Gottschalk B, Ramadani-Muja J, Eroglu E, Rost R, Balfanz S, Baumann A, Waldeck-Weiermair M, Hay JC, Madl T, Graier WF, Malli R.

ACS Sens. 2019 Apr 26;4(4):883-891. doi: 10.1021/acssensors.8b01599. Epub 2019 Mar 30.

9.

Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs.

Siebenga PS, van Amerongen G, Okkerse P, Denney WS, Dua P, Butt RP, Hay JL, Groeneveld GJ.

Eur J Pain. 2019 Feb 21. doi: 10.1002/ejp.1379. [Epub ahead of print]

PMID:
30793411
10.

Glycogen Synthase Kinase 3 Beta Controls Presenilin-1-Mediated Endoplasmic Reticulum Ca²⁺ Leak Directed to Mitochondria in Pancreatic Islets and β-Cells.

Klec C, Madreiter-Sokolowski CT, Stryeck S, Sachdev V, Duta-Mare M, Gottschalk B, Depaoli MR, Rost R, Hay J, Waldeck-Weiermair M, Kratky D, Madl T, Malli R, Graier WF.

Cell Physiol Biochem. 2019;52(1):57-75. doi: 10.33594/000000005. Epub 2019 Feb 18.

11.

Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.

Parsons BG, Hay JL, Aspinwall LG, Zaugg K, Zhu A, Mooney RH, Klein SZ, Grossman D, Leachman SA, Wu YP.

J Cancer Educ. 2019 Feb 15. doi: 10.1007/s13187-019-01489-3. [Epub ahead of print]

PMID:
30771212
12.

Abstract social categories facilitate access to socially skewed words.

Hay J, Walker A, Sanchez K, Thompson K.

PLoS One. 2019 Feb 4;14(2):e0210793. doi: 10.1371/journal.pone.0210793. eCollection 2019.

13.

Evaluation of risk factors for mortality in dogs with lung lobe torsion: A retrospective study of 66 dogs (2000-2015).

Wainberg SH, Brisson BA, Reabel SN, Hay J, Hayes G, Shmon CL, Murphy K, Sears W.

Can Vet J. 2019 Feb;60(2):167-173.

PMID:
30705452
14.

Early onset sepsis calculator-based management of newborns exposed to maternal intrapartum fever: a cost benefit analysis.

Gong CL, Dasgupta-Tsinikas S, Zangwill KM, Bolaris M, Hay JW.

J Perinatol. 2019 Apr;39(4):571-580. doi: 10.1038/s41372-019-0316-y. Epub 2019 Jan 28.

PMID:
30692615
15.

"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.

Hamilton JG, Genoff Garzon M, Westerman JS, Shuk E, Hay JL, Walters C, Elkin E, Bertelsen C, Cho J, Daly B, Gucalp A, Seidman AD, Zauderer MG, Epstein AS, Kris MG.

J Oncol Pract. 2019 Apr;15(4):e277-e288. doi: 10.1200/JOP.18.00417. Epub 2019 Jan 28.

PMID:
30689492
16.

Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination.

Boreskie KF, Kehler DS, Costa EC, Hiebert BM, Hamm NC, Moffatt TL, Hay JL, Stammers AN, Kimber DE, Kent DE, Cornish DE, Arora RC, Strachan SM, Semenchuk BN, Duhamel TA.

Exp Gerontol. 2019 May;119:40-44. doi: 10.1016/j.exger.2019.01.021. Epub 2019 Jan 23.

PMID:
30682391
17.

Word frequency effects in sound change as a consequence of perceptual asymmetries: An exemplar-based model.

Todd S, Pierrehumbert JB, Hay J.

Cognition. 2019 Apr;185:1-20. doi: 10.1016/j.cognition.2019.01.004. Epub 2019 Jan 12.

PMID:
30641466
18.

Cost-Effectiveness Comparison of Ustekinumab, Infliximab, or Adalimumab for the Treatment of Moderate-Severe Crohn's Disease in Biologic-Naïve Patients.

Aliyev ER, Hay JW, Hwang C.

Pharmacotherapy. 2019 Feb;39(2):118-128. doi: 10.1002/phar.2208. Epub 2019 Jan 20.

PMID:
30565265
19.

Pre-Operative Frailty Status Is Associated with Cardiac Rehabilitation Completion: A Retrospective Cohort Study.

Kimber DE, Kehler DS, Lytwyn J, Boreskie KF, Jung P, Alexander B, Hiebert BM, Dubiel C, Hamm NC, Stammers AN, Clarke M, Fraser C, Pedreira B, Tangri N, Hay JL, Arora RC, Duhamel TA.

J Clin Med. 2018 Dec 17;7(12). pii: E560. doi: 10.3390/jcm7120560.

20.

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Cosimo E, Tarafdar A, Moles MW, Holroyd AK, Malik N, Catherwood MA, Hay J, Dunn KM, Macdonald AM, Guichard SM, O'Rourke D, Leach MT, Sansom OJ, Cosulich SC, McCaig AM, Michie AM.

Clin Cancer Res. 2019 Mar 1;25(5):1574-1587. doi: 10.1158/1078-0432.CCR-18-2036. Epub 2018 Dec 17.

PMID:
30559170
21.

Potential inconsistencies in Zika surveillance data and our understanding of risk during pregnancy.

Hay JA, Nouvellet P, Donnelly CA, Riley S.

PLoS Negl Trop Dis. 2018 Dec 10;12(12):e0006991. doi: 10.1371/journal.pntd.0006991. eCollection 2018 Dec.

22.

Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function.

Salcedo J, Hay JW, Lam J.

Int J Cardiol. 2019 May 1;282:53-58. doi: 10.1016/j.ijcard.2018.11.087. Epub 2018 Nov 19.

PMID:
30518479
23.

Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.

Bowen DJ, Hay J, Meischke H, Mayer JA, Harris-Wai J, Burke W.

Cancer Causes Control. 2019 Mar;30(3):225-233. doi: 10.1007/s10552-018-1096-y. Epub 2018 Nov 27.

PMID:
30483971
24.

Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab.

Xu Y, Hay JW, Barzi A.

Cost Eff Resour Alloc. 2018 Nov 12;16:30. doi: 10.1186/s12962-018-0132-9. eCollection 2018.

25.

Differences in Rural and Urban Health Information Access and Use.

Chen X, Orom H, Hay JL, Waters EA, Schofield E, Li Y, Kiviniemi MT.

J Rural Health. 2018 Nov 16. doi: 10.1111/jrh.12335. [Epub ahead of print]

PMID:
30444935
26.

Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc Therapy.

Giambattista J, McVicar N, Hamilton S, Martin M, Maas B, Ho C, Wu J, Tran E, Hay J, Berthelet E.

Cureus. 2018 Sep 13;10(9):e3296. doi: 10.7759/cureus.3296.

27.

Low Health Literacy and Health Information Avoidance but Not Satisficing Help Explain "Don't Know" Responses to Questions Assessing Perceived Risk.

Orom H, Schofield E, Kiviniemi MT, Waters EA, Biddle C, Chen X, Li Y, Kaphingst KA, Hay JL.

Med Decis Making. 2018 Nov;38(8):1006-1017. doi: 10.1177/0272989X18799999.

PMID:
30403579
28.

Vigorous Intervals and Hypoglycemia in Type 1 Diabetes: A Randomized Cross Over Trial.

Rempel M, Yardley JE, MacIntosh A, Hay JL, Bouchard D, Cornish S, Marks SD, Hai Y, Gordon JW, McGavock J.

Sci Rep. 2018 Oct 26;8(1):15879. doi: 10.1038/s41598-018-34342-6.

29.

A systematic review of the association between sedentary behaviors with frailty.

Kehler DS, Hay JL, Stammers AN, Hamm NC, Kimber DE, Schultz ASH, Szwajcer A, Arora RC, Tangri N, Duhamel TA.

Exp Gerontol. 2018 Dec;114:1-12. doi: 10.1016/j.exger.2018.10.010. Epub 2018 Oct 22. Review.

PMID:
30355522
30.

The enigmatic ATP supply of the endoplasmic reticulum.

Depaoli MR, Hay JC, Graier WF, Malli R.

Biol Rev Camb Philos Soc. 2019 Apr;94(2):610-628. doi: 10.1111/brv.12469. Epub 2018 Oct 19.

31.

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Review.

PMID:
30281145
32.

Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States.

Cho SK, Hay JW, Barzi A.

Clin Colorectal Cancer. 2018 Dec;17(4):e751-e761. doi: 10.1016/j.clcc.2018.08.003. Epub 2018 Aug 24.

PMID:
30228027
33.

Transcriptional and Post-Translational Targeting of Myocyte Stress Protein 1 (MS1) by the JNK Pathway in Cardiac Myocytes.

Hay JM, Jordan ES, Browne GJ, Bottrill AR, Prigent SA, Dickens M.

J Mol Signal. 2017 Dec 8;12:3. doi: 10.5334/1750-2187-12-3.

34.

Bacteria-Based Materials for Stem Cell Engineering.

Hay JJ, Rodrigo-Navarro A, Petaroudi M, Bryksin AV, García AJ, Barker TH, Dalby MJ, Salmeron-Sanchez M.

Adv Mater. 2018 Oct;30(43):e1804310. doi: 10.1002/adma.201804310. Epub 2018 Sep 12.

PMID:
30209838
35.

Barriers to physical activity: a study of academic and community cancer survivors with pain.

Romero SAD, Brown JC, Bauml JM, Hay JL, Li QS, Cohen RB, Mao JJ.

J Cancer Surviv. 2018 Dec;12(6):744-752. doi: 10.1007/s11764-018-0711-y. Epub 2018 Sep 4.

PMID:
30182150
36.

Health Literacy and Use and Trust in Health Information.

Chen X, Hay JL, Waters EA, Kiviniemi MT, Biddle C, Schofield E, Li Y, Kaphingst K, Orom H.

J Health Commun. 2018;23(8):724-734. doi: 10.1080/10810730.2018.1511658. Epub 2018 Aug 30.

PMID:
30160641
37.
38.

Do Infants Learn Words From Statistics? Evidence From English-Learning Infants Hearing Italian.

Shoaib A, Wang T, Hay JF, Lany J.

Cogn Sci. 2018 Nov;42(8):3083-3099. doi: 10.1111/cogs.12673. Epub 2018 Aug 22.

PMID:
30136301
39.

Examining the Interrelations Among Objective and Subjective Health Literacy and Numeracy and Their Associations with Health Knowledge.

Waters EA, Biddle C, Kaphingst KA, Schofield E, Kiviniemi MT, Orom H, Li Y, Hay JL.

J Gen Intern Med. 2018 Nov;33(11):1945-1953. doi: 10.1007/s11606-018-4624-2. Epub 2018 Aug 17.

PMID:
30120636
40.

First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective.

Hu X, Hay JW.

Lung Cancer. 2018 Sep;123:166-171. doi: 10.1016/j.lungcan.2018.07.012. Epub 2018 Jul 11.

PMID:
30089590
41.

Exercise in Pregnancy and Children's Cardiometabolic Risk Factors: a Systematic Review and Meta-Analysis.

Guillemette L, Hay JL, Kehler DS, Hamm NC, Oldfield C, McGavock JM, Duhamel TA.

Sports Med Open. 2018 Aug 2;4(1):35. doi: 10.1186/s40798-018-0148-x. Review.

42.

A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma.

Lam J, Hay JW, Salcedo J, Kenyon NJ.

J Asthma. 2018 Aug 29:1-10. doi: 10.1080/02770903.2018.1500584. [Epub ahead of print]

PMID:
30003833
43.

Effects of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training On Blood Pressure in Adults with Pre- to Established Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials.

Costa EC, Hay JL, Kehler DS, Boreskie KF, Arora RC, Umpierre D, Szwajcer A, Duhamel TA.

Sports Med. 2018 Sep;48(9):2127-2142. doi: 10.1007/s40279-018-0944-y. Review.

PMID:
29949110
44.

Prevalence and Correlates of Worry About Medical Imaging Radiation Among United States Cancer Survivors.

Hay JL, Baser RE, Westerman JS, Ford JS.

Int J Behav Med. 2018 Oct;25(5):569-578. doi: 10.1007/s12529-018-9730-3.

PMID:
29872990
45.

Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Hay JL, Zielaskowski K, Meyer White K, Kaphingst K, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Rodríguez VM, Li Y, Schofield E, Bigney J, Hunley K, Buller D, Berwick M.

JAMA Dermatol. 2018 Jun 1;154(6):684-693. doi: 10.1001/jamadermatol.2018.0592.

46.

Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study.

Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis V, Israels S, Grant RM, Fernandez CV, Dix DB, Cummings EA, Couch R, Cairney E, Barr R, Abish S, Atkinson SA, Hay J, Rauch F, Moher D, Siminoski K, Halton J; Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium.

J Bone Miner Res. 2018 Aug;33(8):1435-1443. doi: 10.1002/jbmr.3447. Epub 2018 May 22.

PMID:
29786884
47.

Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes.

Hay JW, Lee PJ, Jin H, Guterman JJ, Gross-Schulman S, Ell K, Wu S.

Value Health. 2018 May;21(5):561-568. doi: 10.1016/j.jval.2017.11.005. Epub 2017 Dec 6.

48.

Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis.

Gong CL, Zangwill KM, Hay JW, Meeker D, Doctor JN.

J Gen Intern Med. 2019 Jun;34(6):846-854. doi: 10.1007/s11606-018-4467-x. Epub 2018 May 8.

PMID:
29740788
49.

In Reply: Bupivacaine Field Block With Clonidine for Postoperative Pain Control in Posterior Spine Approaches: A Randomized Double-Blind Trial.

Maarrawi J, Hay JA.

Neurosurgery. 2018 Aug 1;83(2):E93. doi: 10.1093/neuros/nyy167. No abstract available.

PMID:
29733412
50.

Comparative Effectiveness of a Technology-Facilitated Depression Care Management Model in Safety-Net Primary Care Patients With Type 2 Diabetes: 6-Month Outcomes of a Large Clinical Trial.

Wu S, Ell K, Jin H, Vidyanti I, Chou CP, Lee PJ, Gross-Schulman S, Sklaroff LM, Belson D, Nezu AM, Hay J, Wang CJ, Scheib G, Di Capua P, Hawkins C, Liu P, Ramirez M, Wu BW, Richman M, Myers C, Agustines D, Dasher R, Kopelowicz A, Allevato J, Roybal M, Ipp E, Haider U, Graham S, Mahabadi V, Guterman J.

J Med Internet Res. 2018 Apr 23;20(4):e147. doi: 10.2196/jmir.7692.

Supplemental Content

Support Center